This is a Randomized Study of Early Involvement of Palliative Care Along Side Standard Treatment Versus Standard Treatment Alone in Newly Diagnosed Patients With Advanced or Metastatic Soft Tissue Sarcoma (SARQUALITY)

Inclusion Criteria:

• Signed written and voluntary informed consent.

• Have histologically documented advanced sarcoma, either locally advanced notamenable to curative treatment, or metastatic.

• Age ≥ 18 years.

• Have not received any previous systemic treatment with palliative intent foradvanced sarcoma.

• Performance status of 0-2 on the Eastern Cooperative Oncology Group (ECOG)performance scale.

• Life expectancy > 6 months.

• Willing/able to complete questionnaires.

Exclusion Criteria:

• Clinical evidence of cognitive impairment that would preclude the ability to provideinformed consent and complete questionnaires, at investigator´s discretion.

• Patient in need of urgent home support services or symptom management through apalliative care team.

• Patient is being actively followed by a palliative care physician.

• Active psychiatric disorder or drug abuse.

• Insufficient English literacy to complete questionnaires.